Esperion Therapeutics, Inc (ESPR) insider trading
Every open-market stock purchase and sale by Esperion Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $579K over the last 12 months (11 sales). No open-market buys.
- Last insider buy: J Martin Carroll (Director), $36.3K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $579K (11 sales). Last close $3.13 on Jun 4, 2026.
Recent ESPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Sheldon L. Koenig (CEO) | Sold | $169K |
| Jun 17, 2026 | Benjamin Looker (C-suite exec) | Sold | $37.3K |
| Jun 17, 2026 | Benjamin Halladay (CFO) | Sold | $34K |
| May 28, 2026 | J Martin Carroll (Director) | Bought (not open market) | — |
| May 28, 2026 | Seth H. Z. Fischer (Director) | Bought (not open market) | — |
| May 28, 2026 | Robert E. Hoffman (Director) | Bought (not open market) | — |
| May 28, 2026 | Jay Shepard (Director) | Bought (not open market) | — |
| May 28, 2026 | John Craig Thompson (Director) | Bought (not open market) | — |
| Mar 17, 2026 | Sheldon L. Koenig (CEO) | Sold | $69.5K |
| Mar 17, 2026 | Benjamin Halladay (CFO) | Sold | $17.4K |
| Mar 17, 2026 | Benjamin Looker (C-suite exec) | Sold | $15.4K |
| Mar 13, 2026 | Sheldon L. Koenig (CEO) | Bought (not open market) | — |
| Mar 13, 2026 | Benjamin Halladay (CFO) | Bought (not open market) | — |
| Mar 13, 2026 | Benjamin Looker (C-suite exec) | Bought (not open market) | — |
| Mar 13, 2026 | Benjamin Halladay (CFO) | Bought (not open market) | — |
| Mar 13, 2026 | Benjamin Looker (C-suite exec) | Bought (not open market) | — |
| Mar 13, 2026 | Sheldon L. Koenig (CEO) | Bought (not open market) | — |
| Jan 20, 2026 | Benjamin Looker (General Counsel) | Sold | $4.9K |
| Dec 17, 2025 | Sheldon L. Koenig (CEO) | Sold | $177K |
| Dec 17, 2025 | Benjamin Halladay (CFO) | Sold | $26.9K |
| Dec 17, 2025 | Benjamin Looker (General Counsel) | Sold | $23.9K |
| Dec 4, 2025 | John B. Harlow Jr. (C-suite exec) | Bought (not open market) | — |
| Dec 4, 2025 | John B. Harlow Jr. (C-suite exec) | Bought (not open market) | — |
| Oct 17, 2025 | Benjamin Looker (General Counsel) | Sold | $3.3K |
Who's trading ESPR
- Sheldon L. Koenig, CEO: sold $416K (3 sales), last Jun 17, 2026
- Benjamin Halladay, CFO: sold $78.3K (3 sales), last Jun 17, 2026
- Benjamin Looker, General Counsel: sold $84.8K (5 sales), last Jun 17, 2026
- J Martin Carroll, Director: other filings, last May 28, 2026
- Seth H. Z. Fischer, Director: other filings, last May 28, 2026
- Robert E. Hoffman, Director: other filings, last May 28, 2026
- Jay Shepard, Director: other filings, last May 28, 2026
- John Craig Thompson, Director: other filings, last May 28, 2026
- John B. Harlow Jr., C-suite exec: other filings, last Dec 4, 2025
Get free alerts when an insider at Esperion Therapeutics, Inc files a new trade →